Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) Director Donald Morel, Jr. sold 1,493 shares of the business’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of €17.09, for a total transaction of €25,515.37. Following the completion of the sale, the director owned 37,424 shares in the company, valued at approximately €639,576.16. The trade was a 3.84% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Stevanato Group Stock Down 0.2%
STVN opened at €18.36 on Friday. The firm has a 50-day simple moving average of €17.41 and a two-hundred day simple moving average of €17.26. Stevanato Group S.p.A. has a 52 week low of €12.89 and a 52 week high of €28.00. The company has a market capitalization of $5.56 billion, a PE ratio of 31.11, a price-to-earnings-growth ratio of 1.59 and a beta of 0.78. The company has a quick ratio of 1.11, a current ratio of 1.63 and a debt-to-equity ratio of 0.21.
Stevanato Group (NYSE:STVN – Get Free Report) last issued its quarterly earnings data on Friday, May 8th. The company reported €0.11 earnings per share for the quarter, missing analysts’ consensus estimates of €0.12 by (€0.01). Stevanato Group had a net margin of 11.76% and a return on equity of 10.27%. The firm had revenue of €273.57 million for the quarter. During the same period last year, the firm posted $0.10 EPS. The firm’s quarterly revenue was up 6.6% on a year-over-year basis. Analysts forecast that Stevanato Group S.p.A. will post 0.68 earnings per share for the current fiscal year.
Stevanato Group Cuts Dividend
Analysts Set New Price Targets
A number of analysts have issued reports on STVN shares. Citigroup reduced their price objective on Stevanato Group from $32.00 to $26.00 and set a “buy” rating on the stock in a research note on Thursday, March 5th. Morgan Stanley lowered their target price on Stevanato Group from $24.00 to $19.00 and set an “equal weight” rating for the company in a research report on Friday, March 6th. Weiss Ratings upgraded shares of Stevanato Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, June 18th. TD Cowen raised shares of Stevanato Group to a “strong-buy” rating in a research note on Wednesday, June 17th. Finally, Wolfe Research initiated coverage on shares of Stevanato Group in a research report on Tuesday, June 2nd. They set an “outperform” rating and a $21.00 price objective for the company. Two investment analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Buy”.
Read Our Latest Research Report on Stevanato Group
Institutional Trading of Stevanato Group
Several hedge funds and other institutional investors have recently bought and sold shares of STVN. GW&K Investment Management LLC lifted its position in Stevanato Group by 76.2% in the fourth quarter. GW&K Investment Management LLC now owns 2,440 shares of the company’s stock worth $49,000 after buying an additional 1,055 shares during the last quarter. Fifth Third Bancorp increased its position in Stevanato Group by 22.6% during the first quarter. Fifth Third Bancorp now owns 4,196 shares of the company’s stock valued at $58,000 after acquiring an additional 773 shares during the last quarter. State of Wyoming raised its stake in shares of Stevanato Group by 39,216.7% in the second quarter. State of Wyoming now owns 2,359 shares of the company’s stock valued at $58,000 after acquiring an additional 2,353 shares during the period. Quantbot Technologies LP purchased a new stake in shares of Stevanato Group in the third quarter valued at $68,000. Finally, Tower Research Capital LLC TRC lifted its holdings in shares of Stevanato Group by 1,268.7% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,585 shares of the company’s stock worth $112,000 after acquiring an additional 4,250 shares during the last quarter.
Stevanato Group Company Profile
Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.
In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.
Featured Stories
- Five stocks we like better than Stevanato Group
- BlackBerry’s Rally Is Running on a Bigger AI Story Than Earnings Alone
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
